Bayer Investor News | Bayer Global

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 489 News

1 - 10of 489 News

September 17, 2026

Not intended for U.S. and UK Media

U.S. FDA approves finerenone for new indication in patients with chronic kidney disease associated with type 1 diabetes

September 09, 2026

Not intended for U.S. and UK Media

U.S. FDA grants accelerated approval to Bayer’s targeted therapy sevabertinib as a first-line treatment option for adults with HER2-mutant non-small cell lung cancer

September 09, 2026

Bayer and Neste close commercial agreement to jointly scale newgold® winter canola for biofuels production

September 02, 2026

Bayer advances combined seed and crop protection pipeline and enters phase of blockbuster launches

August 24, 2026

Not intended for U.S. and UK Media

Bayer’s sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer

August 04, 2026

Second quarter of 2026:

Bayer operationally on track, decisive progress on strategic priorities

July 30, 2026

Not intended for U.S. and UK Media

Bayer submits application for next indication of Kerendia in China

July 15, 2026

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer successfully places new U.S. dollar bonds with a volume of 5 billion

July 15, 2026

Bayer signs licensing agreement with RAGT and begins broad hybrid wheat commercialization by early 2030s

July 10, 2026

Bayer secures 3.0 billion euros to improve capital structure

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk